Summary

Report Scope:

The report is designed to be a comprehensive business tool to provide an in-depth look at the market for immunoassays. The geographic scope of the report is global. The report reviews each type of immunoassay and reviews technologies associated with immunoassays and equipment. The report also explores market size, identifies market participants and investigates patents in the immunoassays market.

The global market for immunoassays is divided into categories by immunoassay type and by application as follows.

By product:

Enzyme immunoassays.
Fluorescent immunoassays.
Radioimmunoassays.
Chemiluminescent immunoassays.
Lateral flow immunoassays and multiplex immunoassays.
By application:

Diabetes.
Drug screening.
Infectious diseases.
Cancer.
Cardiology.
Reproductive.
Other immunoassays.
Each area is covered in detail, identifying current products in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.

Report Includes:

- 124 data tables and 4 additional tables
- An up-to-date review and analysis of the global markets for immunoassays and related technologies
- Analyses of the global market trends, with historic sales data for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and revenue forecast for global immunoassays market in USD millions, and corresponding market share analysis based on product type, application, and region
- Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and other region-specific macroeconomic factors affecting the market for immunoassays as a basis for projecting demand over the next few years (2022-2027)
- Insight into prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent breakthrough innovations, clinical trials, and value chain analyses
- Assessment of the recent industry structure for microbiome therapeutics, ongoing research (R&D) activities, analysis of the competitive environment, and COVID-19 impact on the biotech industry
- Review of the patents and patent applications on immunoassays testing and applications
- Competitive landscape of this market featuring leading biopharmaceutical companies, their product portfolios, financial performances, and market share analysis based on recent segmental revenues
- Company profiles of major players within the industry, including Abbott Laboratories, Biomerieux S.A., F. Hoffmann-La Roche Ltd., Siemens Healthineers, and Thermo Fisher Scientific

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Introduction
1.1 Study Goals and Objectives
1.2 Reasons for Doing This Study
1.3 What's New in This Update?
1.4 Scope of Report
1.5 Methodology
1.6 Information Sources
1.6.1 Primary Research
1.6.2 Secondary Research
1.7 Geographic Breakdown
1.8 Analyst's Credentials
1.9 BCC Custom Research
1.10 Related BCC Research Reports
Chapter 2 Summary and Highlights
2.1 Introduction
Chapter 3 Market Overview
3.1 Definitions and Overview
3.1.1 Classifying immunoassays
3.2 Types of Immunoassays
3.2.1 Enzyme immunoassay (EIA)
3.2.2 Radioimmunoassay (RIA)
3.2.3 Fluorescent Immunoassay (FIA)
3.2.4 Chemiluminescent Immunoassay (CLIA)
3.2.5 Lateral Flow Immunoassays (LFIA)
3.2.6 Multiplex Immunoassay (MIA)
3.3 Applications of Immunoassays
3.3.1 Clinical Diagnostics and Drug Monitoring
3.3.2 Biopharmaceutical Analysis
3.3.3 Food Testing
3.3.4 Environmental Monitoring
3.3.5 Diagnostic Tests
Chapter 4 Market Dynamics
4.1 Market Dynamics
4.1.1 Drivers
4.1.2 Trends
4.1.3 Opportunities
4.1.4 Restraints
Chapter 5 Impact of the COVID-19 Pandemic
5.1 Introduction
5.2 Impact of COVID-19 Pandemic on the Medical Device and Pharma Industries
5.3 Impact of the COVID-19 Pandemic on the Medical Device and Pharmaceutical Product Segments
5.4 Impact of the COVID-19 Pandemic on the Market for Immunoassay Tests
Chapter 6 Global Market for Immunoassays
6.1 World Demand for Immunoassays
Chapter 7 Market Breakdown by Type of Test
7.1 Introduction
7.2 Enzyme Immunoassay (ELISA)
7.2.1 North America
7.2.2 Europe
7.2.3 Asia-Pacific
7.2.4 RoW
7.3 Chemiluminescent Immunoassay (CLIA)
7.3.1 North America
7.3.2 Europe
7.3.3 Asia-Pacific
7.3.4 RoW
7.4 Fluorescent Immunoassay (FIA)
7.4.1 North America
7.4.2 Europe
7.4.3 Asia-Pacific
7.4.4 RoW
7.5 Radioimmunoassay (RIA)
7.5.1 North America
7.5.2 Europe
7.5.3 Asia-Pacific
7.5.4 RoW
7.6 Lateral Flow Immunoassay (LFIA)/Multiplex Immunoassay (MIA)
7.6.1 North America
7.6.2 Europe
7.6.3 Asia-Pacific
7.6.4 RoW
Chapter 8 Market Breakdown by Application
8.1 Introduction
8.2 Diabetes
8.2.1 North America
8.2.2 Europe
8.2.3 Asia-Pacific
8.2.4 RoW
8.3 Drug Screening
8.3.1 North America
8.3.2 Europe
8.3.3 Asia-Pacific
8.3.4 RoW
8.4 Infectious Diseases
8.4.1 North America
8.4.2 Europe
8.4.3 Asia-Pacific
8.4.4 RoW
8.5 Cancer
8.5.1 North America
8.5.2 Europe
8.5.3 Asia-Pacific
8.5.4 RoW
8.6 Cardiology
8.6.1 North America
8.6.2 Europe
8.6.3 Asia-Pacific
8.6.4 RoW
8.7 Reproductive Medicine
8.7.1 North America
8.7.2 Europe
8.7.3 Asia-Pacific
8.7.4 RoW
8.8 Other Applications of Immunoassay Tests
8.8.1 North America
8.8.2 Europe
8.8.3 Asia-Pacific
8.8.4 RoW
Chapter 9 Competitive Landscape
9.1 Industry Scenario
9.2 Company Market Shares
9.3 Competitive Landscape by Type of Test
9.4 Competitive Landscape by Application
Chapter 10 Patents
10.1 Patent Analysis by Manufacturer
Chapter 11 Company Profiles
ABBOTT LABORATORIES
ABCAM PLC
BECKMAN COULTER (DANAHER CORP.)
BIOMERIEUX S.A.
BIO-RAD LABORATORIES INC.
DIASORIN
MERCK INC.
MINDRAY
ORASURE TECHNOLOGIES
PERKIN ELMER
QUIDEL CORP.
RANDOX LABORATORIES LTD.
ROCHE DIAGNOSTICS (F. HOFFMANN-LA ROCHE LTD.)
SD BIOSENSOR
SIEMENS HEALTHINEERS
THERMO FISHER SCIENTIFIC INC.
Chapter 12 Appendix: Acronyms